0001225208-23-001909.txt : 20230214 0001225208-23-001909.hdr.sgml : 20230214 20230214163704 ACCESSION NUMBER: 0001225208-23-001909 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230210 FILED AS OF DATE: 20230214 DATE AS OF CHANGE: 20230214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wengel Kathryn E CENTRAL INDEX KEY: 0001745955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 23630450 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0306 4 2023-02-10 0000200406 JOHNSON & JOHNSON JNJ 0001745955 Wengel Kathryn E ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 EVP, Chief TO and Risk Officer Common Stock 2023-02-10 4 M 0 1807.0000 0.0000 A 73117.8735 D Common Stock 2023-02-10 4 F 0 667.0000 162.0800 D 72450.8735 D Common Stock 54.0000 I By 401k Common Stock 281.0000 I By ESOP Restricted Share Units 2023-02-10 4 M 0 1807.0000 0.0000 D 2023-02-10 Common Stock 1807.0000 0.0000 D Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Shares withheld for payment of taxes upon vesting of Restricted Share Units. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023). Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023). Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel 2023-02-14